Recon: US appeals court allows limited access to abortion pill; Novo pens $2.6B deal with cell therapy maker Aspect Biosystems
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy